Glenmark Pharmaceuticals informs about board meeting

16 Oct 2015 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on October 29, 2015, to consider and approve the Company’s Unaudited Financial Statements for the Second Quarter/Half Year ended September 30, 2015 (Q2). Further, as per the ‘Code of Conduct for Prevention of Insider Trading’ of the Company, the trading window closed for Directors and other designated employees of the Company on September 24, 2015 and will remain closed up to November 02, 2015 for the purpose of approval of Unaudited Financial Statements for the Second Quarter/Half Year ended September 30, 2015.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2035.90 6.30 (0.31%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×